International Clinical and Medical Case Reports Journal (ISSN: 2832-5788) | Volume 1, Issue 5 | Case Report | Open Access

Acute Transverse Myelitis Secondary to SARS-CoV-2 Vaccine

Arthur Cecchini*

Department of Internal Medicine, East Tennessee State University, USA

*Correspondence to: Arthur Cecchini 

Fulltext PDF


Acute transverse myelitis secondary to the SARS-CoV-2 vaccine is a rare yet documented phenomenon. We present a case of a 31-year-old male who presented with severe weakness, numbness, tingling, and neuropathic pain below the umbilicus who had recently received the Moderna mRNA SARS-CoV-2 vaccine. An extensive workup revealed no other likely etiology, and he was subsequently diagnosed with MRI-negative acute transverse myelitis related to the SARS-CoV-2 vaccine. A rapid improvement in symptoms and near full recovery occurred with high-dose methylprednisolone and physical therapy.


SARS-CoV-2; Vaccine; Hypertension


Arthur Cecchini DO, Syed Sadiq DO, Ahmad Rashad Othman MD, Koushik Sanku MD, Amanda Cecchini DO.Acute Transverse Myelitis Secondary to SARS-CoV-2 Vaccine.Int Clinc Med Case Rep Jour. 2022;1(4):1-4.